Cargando…

Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings

DAYAS is a new two-part rating scale that assesses: (1) ADHD and ODD symptoms (externalising symptom ratings) and (2) symptomatology potentially related to ADHD medication (potentially medication-related symptoms) in real-world settings at different time periods throughout a normal school day. Data...

Descripción completa

Detalles Bibliográficos
Autores principales: Breuer, Dieter, Görtz-Dorten, Anja, Rothenberger, Aribert, Döpfner, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180560/
https://www.ncbi.nlm.nih.gov/pubmed/21901413
http://dx.doi.org/10.1007/s00787-011-0206-0
_version_ 1782212657830428672
author Breuer, Dieter
Görtz-Dorten, Anja
Rothenberger, Aribert
Döpfner, Manfred
author_facet Breuer, Dieter
Görtz-Dorten, Anja
Rothenberger, Aribert
Döpfner, Manfred
author_sort Breuer, Dieter
collection PubMed
description DAYAS is a new two-part rating scale that assesses: (1) ADHD and ODD symptoms (externalising symptom ratings) and (2) symptomatology potentially related to ADHD medication (potentially medication-related symptoms) in real-world settings at different time periods throughout a normal school day. Data from a proof-of-concept study and two observational trials (Medikinet(®) retard [methylphenidate] and the Equasym XL(®) [methylphenidate] OBSEER study) evaluated: (1) validity of weekly externalising symptom ratings using DAYAS, in place of daily ratings; (2) reliability and internal consistency of DAYAS ratings for externalising symptoms and potentially medication-related symptoms; and (3) convergent and divergent validity of the externalising symptom ratings with existing validated scales. From the proof-of-concept study, daily scores by period of day and during the whole day correlated strongly with equivalent weekly scores (r = 0.83–0.92). Internal consistency of externalising symptom rating scales calculated from pooled data were acceptable or good by period of day (Cronbach’s alpha = 0.68–0.90) and very high for whole day scores (Cronbach’s alpha = 0.88–0.95). Internal consistency of the rating scale for potentially medication-related symptoms was also good for both teacher and parent ratings. From OBSEER data, correlations between FBB-ADHD total symptom scores and ratings on both parent and teacher versions of DAYAS were high (r = 0.73 and r = 0.84, respectively). Correlations between DAYAS and SDQ were highest for the SDQ subscales hyperactivity and conduct problems and substantially lower for pro-social behaviour, peers and emotional problems. The DAYAS rating scale had good internal consistency, and DAYAS scores correlated well with existing validated scales and the SDQ subscales hyperactivity and conduct problems. Weekly DAYAS scores (whole day and by period of day) could be considered a suitable replacement for daily assessment scores. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00787-011-0206-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3180560
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-31805602011-10-04 Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings Breuer, Dieter Görtz-Dorten, Anja Rothenberger, Aribert Döpfner, Manfred Eur Child Adolesc Psychiatry Supplement DAYAS is a new two-part rating scale that assesses: (1) ADHD and ODD symptoms (externalising symptom ratings) and (2) symptomatology potentially related to ADHD medication (potentially medication-related symptoms) in real-world settings at different time periods throughout a normal school day. Data from a proof-of-concept study and two observational trials (Medikinet(®) retard [methylphenidate] and the Equasym XL(®) [methylphenidate] OBSEER study) evaluated: (1) validity of weekly externalising symptom ratings using DAYAS, in place of daily ratings; (2) reliability and internal consistency of DAYAS ratings for externalising symptoms and potentially medication-related symptoms; and (3) convergent and divergent validity of the externalising symptom ratings with existing validated scales. From the proof-of-concept study, daily scores by period of day and during the whole day correlated strongly with equivalent weekly scores (r = 0.83–0.92). Internal consistency of externalising symptom rating scales calculated from pooled data were acceptable or good by period of day (Cronbach’s alpha = 0.68–0.90) and very high for whole day scores (Cronbach’s alpha = 0.88–0.95). Internal consistency of the rating scale for potentially medication-related symptoms was also good for both teacher and parent ratings. From OBSEER data, correlations between FBB-ADHD total symptom scores and ratings on both parent and teacher versions of DAYAS were high (r = 0.73 and r = 0.84, respectively). Correlations between DAYAS and SDQ were highest for the SDQ subscales hyperactivity and conduct problems and substantially lower for pro-social behaviour, peers and emotional problems. The DAYAS rating scale had good internal consistency, and DAYAS scores correlated well with existing validated scales and the SDQ subscales hyperactivity and conduct problems. Weekly DAYAS scores (whole day and by period of day) could be considered a suitable replacement for daily assessment scores. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00787-011-0206-0) contains supplementary material, which is available to authorized users. Springer-Verlag 2011-09-08 2011 /pmc/articles/PMC3180560/ /pubmed/21901413 http://dx.doi.org/10.1007/s00787-011-0206-0 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Supplement
Breuer, Dieter
Görtz-Dorten, Anja
Rothenberger, Aribert
Döpfner, Manfred
Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
title Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
title_full Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
title_fullStr Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
title_full_unstemmed Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
title_short Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
title_sort assessment of daily profiles of adhd and odd symptoms, and symptomatology related to adhd medication, by parent and teacher ratings
topic Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180560/
https://www.ncbi.nlm.nih.gov/pubmed/21901413
http://dx.doi.org/10.1007/s00787-011-0206-0
work_keys_str_mv AT breuerdieter assessmentofdailyprofilesofadhdandoddsymptomsandsymptomatologyrelatedtoadhdmedicationbyparentandteacherratings
AT gortzdortenanja assessmentofdailyprofilesofadhdandoddsymptomsandsymptomatologyrelatedtoadhdmedicationbyparentandteacherratings
AT rothenbergeraribert assessmentofdailyprofilesofadhdandoddsymptomsandsymptomatologyrelatedtoadhdmedicationbyparentandteacherratings
AT dopfnermanfred assessmentofdailyprofilesofadhdandoddsymptomsandsymptomatologyrelatedtoadhdmedicationbyparentandteacherratings